Effectiveness & Safety of RF Microneedling and PRP in Treating Pigmentary Disorders
203632036320363microneedlingNext Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium interviewed Dr. Robyn Siperstein, a dermatologist in Boca Raton and Boynton Beach, FL. Watch as Dr. Siperstein explains how modalities such as microneedling can both increase and decrease pigment. Listen as she shares tips on getting the desired pigmentary effect. Hear about her pilot studies on combination therapies t …
microneedling
Eruptive Squamous Cell Carcinomas Following Treatment With Fludarabine
203252032520325Eruptive squamous cell carcinoma JDD authors Mihir Shah MD, Jenna Wald MD, and C. William Hanke MD MPH present a case of a patient with eruptive squamous cell carcinomas following treatment with Fludarabine to highlight not only the risk of cSCC in CLL patients and the increased risk for atypical cutaneous malignancies after treatment with systemic therapies such as fludarabine, but also to discuss treatment options for this …
Eruptive squamous cell carcinoma
Cicatricial Alopecias: Practical Pearls for Challenging Diagnoses
202942029420294cicatricial alopeciasAt ODAC 2023, we had the opportunity to learn about cicatricial alopecias from renowned dermatologist and hair expert Dr. Amy McMichael, Professor of Dermatology at Wake Forest University School of Medicine. First, we considered a framework to check for cicatricial alopecias. This is particularly important because if we can identify cicatricial alopecia, we can make sure we are treating the rig …
cicatricial alopecias
Topical Ruxolitinib Therapeutic Cheat Sheet
202782027820278RuxolitinibRuxolitinib (OPZELURA) is a twice daily topical cream that is FDA approved for non-segmental vitiligo and mild to moderate atopic dermatitis1. JAK inhibitors are a class of drugs effective in treating a wide variety of inflammatory conditions. Initially only FDA approved for non-dermatologic conditions such as rheumatoid arthritis and ulcerative colitis, there is now strong evidence that JAK/STAT …
Ruxolitinib
Benefits and Risks of Medium & Deep Chemical Peels
182651826518265chemical peelsNext Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium (PDE) interviewed Dr. Jennifer Rullan, a dermatologist in Chula Vista, Calif. Watch as Dr. Rullan outlines unexpected ingredients that dermatologists can use in medium depth and deep chemical peels to treat pigmentary disorders, and it may not be the disorders that you expect. Vitiligo? Idiopathic guttate hypomelanosis …
chemical peels